Back to search
FDAFDA · Food and drugs·Recall number Z-0609-2013

Diamigo i-Phone App The Diamigo app was intended for use as an educational tool in the management of diabetes.

Published January 2, 2013 · Recall initiated: September 21, 2012

Summary

FDA records medical device Class II recall Z-0609-2013, published January 2, 2013 and initiated September 21, 2012. Recalling firm: sanofi-aventis US, Inc.; Status: Terminated; Reported quantity: 1600 downloads (140 US; 1460 Foreign). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Diamigo, a software application, was released through the i-Phone Global Store which inadvertently allowed global access to the application as opposed to the original intended restriction of access to Brazil.

What to do

Voluntary: Firm initiated · Other

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
sanofi-aventis US, Inc.
Distributor
Worldwide distribution.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Diamigo i-Phone App The Diamigo app was intended for use as an educational tool in the management of diabetes. recalled?

Yes. FDA published recall Z-0609-2013 on January 2, 2013. Reported hazard: Diamigo, a software application, was released through the i-Phone Global Store which inadvertently allowed global access to the application as opposed to the original intended restriction of access to Brazil.

What should I do if I have this product?

Voluntary: Firm initiated · Other